Post-effective amendment to a registration statement that is not immediately effective upon filing

Consolidated Statements of Changes in Shareholders' Equity

v3.22.0.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Before Recapitalization [Member]
Common Stock
Common Stock
Before Recapitalization [Member]
Common Stock
Recapitalization Adjustment [Member]
Additional Paid-in Capital
Additional Paid-in Capital
Before Recapitalization [Member]
Additional Paid-in Capital
Recapitalization Adjustment [Member]
Accumulated other comprehensive income
Accumulated other comprehensive income
Before Recapitalization [Member]
Accumulated Deficit
Accumulated Deficit
Before Recapitalization [Member]
Redeemable Convertible Preferred stock
Preferred stock
Redeemable Convertible Preferred stock
Preferred stock
Before Recapitalization [Member]
Redeemable Convertible Preferred stock
Preferred stock
Recapitalization Adjustment [Member]
Beginning balance at Dec. 31, 2019 $ (82,225) $ (82,225) $ 3 $ 0 $ 3 $ 38,961 $ 38,964 $ (3) $ 125 $ 125 $ (121,314) $ (121,314) $ 763,815 $ 763,815  
Beginning balance (in shares) at Dec. 31, 2019     263,572,316 121,414,839 142,157,477               290,425,630 133,784,888 156,640,742
Issuance of common stock upon exercise of stock options (in shares)     3,433,498                        
Issuance of common stock upon exercise of stock options 2,952         2,952                  
Repurchase of series B redeemable convertible preferred stock (in shares)                         (125,083)    
Repurchase of series B redeemable convertible preferred stock                         $ (532)    
Unrealized loss on held for sale investments (125)               $ (125)            
Vesting of early exercised stock options (in shares)     2,262,645                        
Vesting of early exercised stock options 388         388                  
Vesting of restricted stock (in shares)     9,542,168                        
Stock-based compensation 16,880         16,880                  
Net loss (214,449)                   (214,449)        
Ending balance (in shares) at Dec. 31, 2020     278,810,627                   290,300,547    
Ending balance at Dec. 31, 2020 (276,579)   $ 3     59,181         (335,763)   $ 763,283    
Issuance of common stock upon exercise of stock options (in shares)     8,393,301                        
Issuance of common stock upon exercise of stock options 7,847         7,847                  
Issuance of series U-1 redeemable convertible preferred stock at $9.06 per share in relation to acquisition (in shares)                         110,437,359    
Issuance of series U-1 redeemable convertible preferred stock at $9.06 per share in relation to acquisition                         $ 1,000,000    
Issuance of series U-2 redeemable convertible preferred stock at $9.06 per share, net of issuance costs of $2,138 (in shares)                         44,174,944    
Issuance of series U-2 redeemable convertible preferred stock at $9.06 per share, net of issuance costs of $2,138                         $ 397,862    
Issuance of common stock in relation to acquisitions (in shares)     257,863,127                        
Issuance of common stock in relation to acquisitions 937,668   $ 3     937,665                  
Purchase consideration allocated to non-cash compensation expense 7,873         7,873                  
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization (in shares)     444,912,850                   (444,912,850)    
Conversion of convertible preferred stock into common stock in connection with the reverse recapitalization 2,161,145   $ 4     2,161,141             $ (2,161,145)    
Issuance of common stock upon the reverse recapitalization, net of issuance costs (in shares)     129,294,175                        
Issuance of common stock upon the reverse recapitalization, net of issuance costs 1,040,521   $ 1     1,040,520                  
Issuance of common stock upon vesting of restricted stock units (in shares)     917,959                        
Common stock withheld for net share settlement of equity awards (in shares)     (302,418)                        
Common stock withheld for net share settlement of equity awards (3,705)         (3,705)                  
Vesting of early exercised stock options (in shares)     1,271,075                        
Vesting of early exercised stock options 182         182                  
Vesting of restricted stock (in shares)     1,669,118                        
Stock-based compensation 222,203         222,203                  
Net loss (755,453)                   (755,453)        
Ending balance (in shares) at Dec. 31, 2021     1,122,829,814                   0    
Ending balance at Dec. 31, 2021 $ 3,341,702   $ 11     $ 4,432,907         $ (1,091,216)   $ 0